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Radix Astragali (RA), known as “Huangqi” in China, is one of the most popular herbal medicines known worldwide to reinforce
“Qi”.RAistraditionallypreparedfromthedriedrootsofAstragalusmembranaceus(MJHQ)andA.membranaceusvar.mongholicus
(MGHQ). Radix Hedysari is named “Hongqi” (HQ), which is similar to RA. We assessed and compared the chemical constituents
and bioactivity of RA and HQ. Diﬀerent constituents were extracted into ﬁve major parts and were analyzed using diﬀerent
methods. Comparison of the immunological eﬀects of extracts was done by using two immunological models. Results showed
that ﬂavonoids and saponins present in RA and HQ were not only structurally signiﬁcantly diﬀerent but also diﬀerent in their
immunological eﬀect. Amino acids extract (AE) in MGHQ shows immunological eﬀect while AE in MJHQ and HQ did not.
Polysaccharides comprised the major constituents in RA and HQ. All polysaccharides extract (PE) of the three herbs showed
similar levels of immunological eﬀect in both immunological assays.
1.Introduction
Radix Astragali (RA), known as Huangqi, which is the
root either of Astragalus membranaceus (Fisch.) Bge. var.
mongholicus (Bge.) Hsiao (MGHQ) or A. membranaceus
(Fisch.) Bge. (MJHQ), has been widely used as an immunos-
timulant, cardiotonic, hepatoprotective, antidiabetic, and
antiviraldrug[1–3].Itissaidtobeneﬁtthedeﬁciencyof“Qi”
(the vital energy) of the spleen that symptomatically presents
as fatigue, diarrhea, and lack of appetite. The constituents
most often associated with the activity of RA are ﬂavonoids,
saponins, polysaccharides, amino acids, and various trace
elements [4–6]. In recent years, RA is mostly obtained from
cultivated plants, as wild ones are increasingly scarce. Most
of the herbs sold commercially are MGHQ [7].
RadixHedysari,knownasHongqi(HQ),isthedriedroot
of Hedysarum polybotrys Hand.-Mazz., which belongs to the
same family as RA. Although HQ has been considered an
authentic and speciﬁcally diﬀerent medicine since 1985, as
recorded in the Chinese Pharmacopoeia, traditionally these
two herbs were often used in the same way [8]. Today in the
northwestofChina,HQisstillwidelyusedinclinicalpractice
instead of RA. The main chemical constituents of HQ are
ﬂavonoids, saponins, benzofurans, organic acids, lignans,
and polysaccharides [8–10]. Comparison of the quality of
these two herbs has a long history. In “shen nong ben cao
jing”, HQ is recorded as one of the species used as RA,
and as being of better quality. HQ is mainly cultivated in
Gansu province and especially used in the Southeast Asia
market.
As far as the known analysis methods, scanning thin-
layerchromatography(TLC),high-performanceliquidchro-
matography (HPLC), high-speed counter-current chro-
matography (HSCCC), capillary HPLC, and a colorimetric
method were used to determine the identify, and levels of
the main constituents in RA and HQ [11–15]. In order to
separate, identify and quantify multicomponents, reverse-
phase HPLC/photodiode array detector, evaporative light
scattering detector, and MS detection were used.
It has been reported, that the main pharmacolog-
ical bioactivities of RA included cardioprotective, hep-
atoprotective, hypotensive, immunostimulant, antiageing,2 Journal of Biomedicine and Biotechnology
antioxidant, antidiabetic, and antiinﬂammatory activities
[16–20]. HQ has also showed activity in cardiovascular
and circulatory functions, immunological beneﬁts, antiaging
eﬀect, antiviral activity, hepatoprotective, antiinﬂammatory
and analgesic activities [8, 21].
Compared to RA, HQ diﬀers in several ways. HQ
seems to have weaker activities in hypotension, circulatory
improvement, and protection from cerebral ischemia, as
demonstrated by animal model testing [22]. Therefore, in
the context of clinical application, comparative evaluation
of the pharmacological eﬀects of RA and HQ is urgently
needed. The present study just represents such a comparative
study on the chemical constituents and immunological eﬀect
between RA and HQ for clinical application.
2.MaterialsandMethods
2.1.ExperimentalAnimals. NIHmice(GradeII,5weeksold)
weighing 18–22g were purchased from Guangdong Exper-
imental Animal Center (Certiﬁcate no. SCXK2008A021,
Guangdong, China). Half of them were males and half were
females. All procedures were in strict accordance with the
PR China legislation on the use and care of laboratory
animals and with the guidelines established by Guangdong
Pharmacological University.
2.2. Plant Material. MGHQ and MJHQ were obtained from
Chifeng, Neimenggu; HQ was obtained from Wudu, Gansu.
The plant materials were identiﬁed by Dr. CHEN Hu-Biao,
School of Chinese Medicine, Hong Kong Baptist University.
The voucher specimens are deposited at the Herbarium,
School of Chinese Medicine, Hong Kong Baptist University.
2.3. Extraction of Chemical Constituents. Reagent grade
methanol, ethanol, acetic ether, n-butanol, ammonia water,
hydrochloric acid, and sodium hydroxide were purchased
from Lab-scan (Bangkok, Thailand). IR-120H ion-exchange
resin was purchased from Aldrich (USA). Water was puriﬁed
usingaMilli-Qwatersystem(Millipore;Bedford,MA,USA).
We extracted the diﬀerent constituents into ﬁve major
parts. There were total extract (TE), ﬂavonoids extract (FE),
saponins extract (SE), polysaccharides extract (PE), and
amino acids extract (AE).
The method of TE extraction: 0.5kg of powdered dried
roots were reﬂuxed 3 times with 3L of MeOH (MeOH/ H2O,
50/50) for 1hour, then ﬁltered; the residues were reﬂuxed 3
timeswith3Lofwaterfor1hourinaglassﬂask,thenﬁltered.
T h eﬁ n a le x t r a c t sw e r ec o n c e n t r a t e dt o5 0 0m Li nv a c u u m .
The procedure for the other extractions was shown in
Figure 1. Flavonoids extract (FE), saponins extract (SE),
polysaccharides extract (PE), and amino acids extract (AE)
were dried in a vacuum oven (Cornelius, OR, USA) to
constant weight.
2.4. Analysis of Flavonoids and Saponins. The ﬂavonoids and
saponins in MGHQ, MJHQ, and HQ were analyzed by
ultra-performance liquid chromatography/mass spectrome-
try (UPLC/MS). 2mL of TE of MGHQ, MJHQ, and HQ and
1mg of FE, SE of MGHQ, MJHQ, and HQ were weighed
for determination. The samples were dissolved in a 10-mL
volumetric ﬂask with MeOH/H2O (50 : 50, v/v) and then
ﬁlteredthroughasyringeﬁlter(0.2μm,Alltech,Beerﬁeld,IL,
USA). An aliquot of 4μL sample solution was injected for
UPLC/TOF-MS analysis. UPLC was performed on a Waters
ACQUITY UPLC system (Waters, Milford, MA), which was
equipped with a binary solvent delivery manager, column
manager, sample manager, and diode array detector (DAD);
it was used for quantitative analysis and UV acquisition. For
mass spectrometric determination, the UPLC-DAD system
was hyphenated to a Bruker MicrOTOFQ system by an
electrospray ionization (ESI) interface (Bruker Daltonics,
Bremen, Germany). For chromatographic separation, an
Acquity UPLC BEH C18 column, 1.7μm, 2.1×150mm
(Waters, Milford, MA) was used. The mobile phase consisted
of 0.1% of formic acid in water (A) and 0.1% of formic
acid in acetonitrile (B) using a gradient program of 10–
40% B in 0–12 minutes, 40–70% B in 12–18 minutes,
and 70–100% B in 18–22 minutes. The solvent ﬂow rate
was 0.3mL/min and the column temperature was set at
30
◦C. The conditions of MS analysis in the negative ion
mode were as follows: capillary voltage, 2.0kV; cone voltage,
0.035kV; the desolvation gas ﬂow, 500L/h; the desolvation
temperature, 350
◦C; and source temperature, 100
◦C. The
acquired m/z was from 100 to 1500. Acetonitrile of LC grade
and methanol of analytical grade were purchased from Lab-
scan (Bangkok, Thailand). Formic acid of LC grade was
purchased from Merck (Darmstadt, Germany). Water was
puriﬁed using a Milli-Q water system (Millipore, Bedford,
MA, USA).
2.5. Quantitative Analysis of Polysaccharides. Polysaccharides
extracts (PE) were redissolved in water and were hydrolyzed,
dehydrated, and polymerized to form a colored complex in
the presence of sulfuric acid and anthrone. The colored com-
plex was measured quantitatively with an ultraviolet/visible
spectrophotometer (Jasco V-530 UV/Vis spectrophotometer,
Japan) at 625nm [3]. 10mg of PE of MGHQ, MJHQ, and
HQ was dissolved in 100mL of water for polysaccharide
determination. Prepared samples were adjusted to a volume
of 2.0mL, and then 6.0mL of 0.1% anthrone-sulfuric acid
(prepared just before use) was added to each tube. The tubes
were placed in a water bath (99
◦C) for 15minutes with
occasional shaking and then cooled in an ice water bath
for 15minutes. The samples were then used for UV/Visible
analysis.
2.6. Quantitative Analysis of Amino Acids. 500mg of AE of
MGHQ, MJHQ, and HQ was dissolved in 600μLo fw a t e r
for amino acid determination. A Hitachi 855-350 auto
amino acid detector (Hitachi, Japan), 150mm × 2.6mm
ion-exchange column at 57
◦C and 10297kPa, ﬂow rate
0.225mL/h, running time 59minutes, and 20μLs a m p l e ,
was used. The detection wavelengths were set at 570nm and
440nm [11].
2.7. Assay of Immune-Organ Index and Index of Car-
bon Grain Elimination. Cyclophosphamide and levamisoleJournal of Biomedicine and Biotechnology 3
1kgofpowdereddriedroots
Reﬂuxed 3 times with 3L of MeOH/H2O
(50 : 50, v/v) for 1h, ﬁltered
Filtrate I Filter residue
Reﬂuxed 3 times with 3L of
water for 1h, ﬁltered
Filtrate I Filter residue
Concentrated
Concentrated solution (1L)
EtOH was added until EtOH was about
70%. The solution was kept airtight for
12h, and then, it was ﬁltered under vacuum
EtOH solution I Deposition
1L water was added and concentrated
to 500mL
Concentrated solution
EtOH was added until EtOH was about
80%. The solution was kept airtight for
24h, and then, ﬁltered under vacuum
EtOH solution II Deposition
Washed with EtOH 2
times and lyophilized Concentrated and ﬁltered
Polysaccharides extract (PE)
Extract
Dissolved in 250mL of water and
extracted 3 times using ethyl
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Concentrated and lyophilized Extracted 3 times using n-butanol
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n-butanol extract Water extract
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cation exchange resin (4.5cm
× 60cm), washed to
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washed with 5% ammonia water
Saponins extract (SE)
Water solution Ammonia water solution
Concentrated
Amino acids extract (AE)
Figure 1: Procedures for FE, SE, PE, AE.
hydrochloride were purchased from Shanghai Hualian Phar-
maceutical Ltd. (Shanghai, China). Drawing ink was pur-
chased from Shanghai Haiwen Ltd. (Shanghai, China).
A total of 180 NIH mice were randomly divided into 18
groups, namely, normal control (NC), model (M), positive
control (PC), and 15 experimental groups designed as:
MGHQ-TE, MGHQ-FE, MGHQ-SE, MGHQ-PE, MGHQ-
AE, MJHQ-TE, MJHQ-FE, MJHQ-SE, MJHQ-PE, MJHQ-
AE, HQ-TE, HQ-FE, HQ-SE, HQ-PE, and HQ-AE.
Herbal extracts was administered to the animals in
experimental groups intragastrically at a dose of 560mg/kg
of body weight per day for ten consecutive days. Distilled
water was administered to the animals in the normal
control and model groups at a dose of 560mg/kg of body
weight per day for ten consecutive days. The solution of
levamisole hydrochloride was administered to the animals
in the positive control group at a dose of 12mg/kg of body
weight per day for ten consecutive days. The solution of
cyclophosphamide were administered to the animals in the
groups (except the normal control group) intragastrically at
adoseof100mg/kgofbodyweightafter1hourfollowingthe
drug administration in the second day for two consecutive
days. After 1 hour following the last drug administration,
mice were injected via the tail vein with colloidal carbon
suspension, consisting of drawing ink. At 30s and 6 minutes
after the injection of the carbon suspension, 20μLa l i q u o t
of the blood were taken from the orbital plexus with a
heparinised haematocrit tube, then immediately mixed with4 Journal of Biomedicine and Biotechnology
2ml of 0.1% (w/v) Na2CO3. The concentration of the
colloidal carbon was estimated by absorbance using a 721-
spectrophotometer at 675nm.
The clearance rate of carbon was expressed as the index
of phagocytosis in the blood (K), calculated by means of
the following equation: K = (log A1 − log A2)/(t1 − t2),
where A1 and A2 are the optical densities at times t1 and t2,
respectively. After blood sample collection, all the mice were
sacriﬁced by dislocation of the cervical vertebrae and the
immune organs including spleens and thymus glands were
isolated and weighed. The indexes of the immune organs
were calculated.
2.8. Assay of Serum Hemolysin to SRBC. Cyclophosphamide
and levamisole hydrochloride were purchased from Shang-
hai Hualian Pharmaceutical Ltd. (Shanghai, China). Sheep
erythrocytes were purchased from Jingmei Ltd. (Guangzhou,
China).
A total of 180 NIH mice were randomly divided into 18
groups, namely, normal control (NC), model (M), positive
control (PC), and 15 experimental groups designed as:
MGHQ-TE, MGHQ-FE, MGHQ-SE, MGHQ-PE, MGHQ-
AE, MJHQ-TE, MJHQ-FE, MJHQ-SE, MJHQ-PE, MJHQ-
AE, HQ-TE, HQ-FE, HQ-SE, HQ-PE, and HQ-AE.
Herbal extracts was administered to the animals in
experimental groups intragastrically at a dose of 560mg/kg
of body weight per day for ten consecutive days. Distilled
water was administered to the animals in the normal
control and model groups at a dose of 560mg/kg of body
weight per day for ten consecutive days. The solution of
levamisole hydrochloride was administered to the animals
in the positive control group at a dose of 12mg/kg of body
weight per day for ten consecutive days. The solution of
cyclophosphamide were administered to the animals in the
groups except the normal control group by hypodermic
injection at a dose of 40mg/kg of body weight following the
drug administration on the ﬁrst day for three consecutive
days. Except for the normal control group, 5% suspensions
of sheep erythrocyte were administered to the animals by
intraperitoneal injection at a dose of 0.2mL per mouse
following the drug administration in the second day.
On the seventh day, 1mL blood was collected by retro-
orbital venous plexus puncture. 0.5mL of 20% sheep red
blood cell (SBRC) was added to 1mL diluted sera, followed
by 1mL guinea pig plasma in sequence. For the normal
controls, the complement was substituted with saline. The
sample and control were incubated for 10minutes at 37
◦C,
and then immersed in an ice-water bath to stop the reaction.
Each sample was centrifuged 10 minutes at 2000rpm, and
the supernatant was analyzed by hemoglobinometry. Color
comparisons were detected using a 721-spectrophotometer
at 540nm wavelength. The absorbance for each sample was
recorded and hemolytic complement activity (HC50)w a s
calculated by means of the following equation: HC50 =
OD1/OD2 × dilution factors, where OD1 and OD2 are the
optical densities of sample and SRBC, respectively.
2.9. Statistical Analysis. The data were analyzed using one-
way ANOVA and expressed as mean ± standard deviation
Table 1: Weights of extracts of MGHQ, MJHQ and HQ (g/kg).
MGHQ MJHQ HQ
FE 3.3611 4.2065 4.9359
SE 11.5036 9.9575 17.7941
PE 49.5570 61.2505 85.0800
AE 16.2292 12.8310 18.4242
(S.D.), n = 10. Signiﬁcant diﬀerences between groups were
detected by Duncan’s multiple range test using SPSS 12.0
software. Student’s t-test was used for comparison between
two groups.
3. Results and Discussion
3.1. Contents of Each Extract. Flavonoids extract (FE), sap-
onins extract (SE), polysaccharides extract (PE), and amino
acids extract (AE) were dried in the vacuum oven to
constant weight. The results are listed in Table 1.W ec a n
ﬁnd out that HQ had the greatest amounts of all ﬁve
constituents. And the contents of PE (85.0800g/kg) and SE
(17.7941g/kg)inHQweremuchhigherinbothofthemthan
in MGHQ and MJHQ. MGHQ had the smallest amounts of
FE(3.3611g/kg)andPE(49.5570g/kg),whileMJHQhadthe
smallest amounts of SE (9.9575g/kg) and AE (12.8310g/kg).
3.2. UPLC/TOF-MS Results. The mass spectrometric con-
ditions were optimized in both positive and negative ion
modes; the negative ion mode was found to be more
sensitive. Most constituents exhibited their quasimolecular
ions [M −H]
−and [M+HCOOH −H]
− in the negative ion
mode.
Based on comparison with chromatograms of standards
compounds and comparison of their m/z values and UV
spectra with the literature [23–25] ,1 7p e a k sw e r ei d e n t i ﬁ e d .
They are: calycosin-7-O-β-D-glucoside (1), ononin (2),
naringin (3), (6aR, 11aR)-9,10-dimethoxypterocarpan-3-O-
β-D-glucopyranoside (4), (3R)- 2 -hydroxy-3 ,4  -dimethyl-
isoﬂavan-7-O-β-D-glucopyranoside (5), calycosin (6), soy-
asaponin II (7), astragaloside IV (8), formononetin (9),
astragaloside II (10), astramembrannin II (11), isoatraga-
losides II (12), astragaloside I (13), soyasaponin I (14),
isoastragaloside I (15), acetylastragaloside I (16), medicarpin
(17).Thestructuresoftheidentiﬁedcompoundswereshown
in Figure 2. The UPLC/TOF-MS analysis, giving accurate
mass measurements of the compounds in TE of MGHQ,
MJHQ, and HQ is shown in Table 2.
The UPLC-UV chromatogram (190–440nm) and base
peak chromatograms (BPC) of samples were analyzed, and
results are shown in Figure 3. 13 compounds including 6
ﬂavonoids and 7 saponins as calycosin-7-O-β-D-glucoside
(1), ononin (2), (6aR, 11aR)-9,10-dimethoxypterocarpan-
3-O-β-D-glucopyranoside (4), (3R)-2 -hydroxy-3 ,4  -dim-
ethyl-isoﬂavan-7-O-β-D-glucopyranoside (5), calycosin (6),
astragaloside IV (8), formononetin (9), astragaloside II (10),
astramembrannin II (11), isoatragaloside II (12), astragalo-
side I (13), isoastragaloside I (15), acetylastragaloside I (16)Journal of Biomedicine and Biotechnology 5
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Figure 2: Chemical structures of the compounds identiﬁed in the UPLC chromatograms.6 Journal of Biomedicine and Biotechnology
Table 2: Accurate mass measurements of the compounds in MGHQ, MJHQ, and HQ as revealed by UPLC/TOF-MS analysis in negative
mode.
Peak no. tR (min) Selected ion m/z Compound identiﬁcation
1 4.33 [M+HCOOH −H]
− 491.1221 calycosin-7-O-β-D-glucoside
2 6.66 [M+HCOOH −H]
− 475.1225 ononin
3 6.75 [M+HCOOH −H]
− 625.2927 naringin
4 7.19 [M+HCOOH −H]
− 507.1475 (6aR, 11aR)-9,10-dimethoxypterocarpan-3-O-β-D-glucopyranoside
57 . 8 6[ M −H]
− 463.1603 (3R)-2 -hydroxy-3 ,4  -dimethoxyisoﬂavan-7-O-β-D-glucopyranoside
68 . 9 3[ M −H]
− 283.061 calycosin
7 10.46 [M+HCOOH −H]
− 957.5071 soyasaponin II
8 11.69 [M+HCOOH −H]
− 829.462 astragaloside IV
9 12.16 [M −H]
− 267.0686 formononetin
10 12.47 [M+HCOOH −H]
− 871.4798 astragaloside II
11 12.70 [M+HCOOH −H]
− 667.4065 astramembrannin II
12 13.09 [M+HCOOH −H]
− 871.4722 isoastragaloside II
13 14.28 [M+HCOOH −H]
− 913.4913 astragaloside I
14 14.37 [M −H]
− 941.5078 soyasaponin I
15 14.60 [M+HCOOH −H]
− 913.4836 isoastragaloside I
16 16.05 [M+HCOOH −H]
− 955.4894 acetylastragaloside I
17 16.28 [M+HCOOH −H]
− 315.2524 medicarpin
Table 3: Polysaccharide content in MGHQ, MJHQ and HQ.
Sample Conc. Absorbance G Conc. Amount in PE Content G Content
(mg/L) (mg/L) Sample (%) (g) (g/kg)
MGHQ-PE 100.00 0.1873 21.43038 21.43 49.5570 10.621
MJHQ-PE 100.00 0.1630 18.35443 18.35 61.2505 11.242
HQ-PE 100.00 0.2152 24.96203 24.96 85.0800 21.238
were detected in both MGHQ and MJHQ. 8 compounds
comprising 6 ﬂavonoids and 2 saponins namely, calycosin-7-
O-β-D-glucoside (1), ononin (2), naringin (3), calycosin (6),
soyasaponin II (7), formononetin (9), soyasaponin I (14),
and medicarpin (17) were detected in HQ; Naringin (3),
soyasaponin II (7), soyasaponin I (14), and medicarpin (17)
were only detected in HQ. The results show that MGHQ
and MJHQ have similar ﬂavonoid and saponin constituents,
while ﬂavonoids and saponins constituents in HQ were
signiﬁcantly diﬀerent. The saponins in HQ are oleanane
pentacyclic triterpenoids, while the saponins in MGHQ and
MJHQ are cycloartane tetracyclic triterpenoids.
3.3. Determination of Polysaccharides. The polysaccharide
contents of MGHQ, MJHQ, and HQ were calculated and
are shown in Table 3. The results show that the contents
of polysaccharides in HQ (21.238g/kg) are much higher
than, indeed, almost double, that in MGHQ (10.621g/kg)
and MJHQ (11.242g/kg). MGHQ and MJHQ had similar
polysaccharide contents, which agrees with earlier work [26,
27]. The references, however, show that the polysaccharide
contents in MJHQ diﬀer in specimens from diﬀerent places
[26], thus it is hard to draw conclusion about the diﬀerence
in the polysaccharide contents of MGHQ and MJHQ in this
study. Further work on specimens of MGHQ and MJHQ
from diﬀerent places is needed.
3.4. Determination of Amino Acids. Seventeen amino acids
were determined to be present in the extracts as follows:
aspartic acid (Asp), serine (Ser), glutamic acid (Glu),
glycine (Gly), alanine (Ala), cysteine (Cys), valine (Val),
methionine (Met), isoleucine (Ile), leucine (Leu), tyrosine
(Tyr), phenylalanine (Phe), lysine (Lys), asparagines (Asn),
histidine (His), arginine (Arg), proline (Pro). Val, Met, Ile,
Leu, Phe, and Lys are essential amino acids. His and Arg are
semidispensable amino acids.
TheaminoacidcontentsofMGHQ,MJHQandHQwere
calculatedandareshowninTable 4.Theresultsshowthatthe
contents of total amino acids in MGHQ (3.7111g/kg) and
HQ (3.5333g/kg) were higher than in MJHQ (2.3244g/kg),
and highest in MGHQ. The contents of Glu, Cys, Met, Tyr
andPheinMJHQwerehigherthanthoseinMGHQandHQ.
In addition, the content of Ser in MJHQ is too low to be
quantiﬁed.
3.5. Eﬀect on the Immune-Organs and Macrophages. The
nonspeciﬁc immunological eﬀects of the extracts were tested
by measuring the immune-organ weights and phagocyticJournal of Biomedicine and Biotechnology 7
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Figure 4: Eﬀects of diﬀerent extracts on mice immune organs and phagocytosis ##P<. 01 and #P<. 05 versus the normal control group.
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Table 4: Amino acid contents of MGHQ, MJHQ, and HQ (g/kg).
No. Amino acid MGHQ-AE MJHQ-AE HQ-AE
1 Asp 0.7859 0.4103 0.8778
2 Ser 0.0327 ∗ 0.0411
3 Glu 0.5772 0.6792 0.5534
4 Gly 0.0121 0.0096 0.0108
5 Ala 0.0965 0.0718 0.1895
6 Cys 0.0099 0.0241 0.0096
7 Val 0.0335 0.0297 0.0424
8 Met 0.0120 0.0477 0.0169
9 Ile 0.0077 0.0037 0.0064
10 Leu 0.0063 0.0052 0.0023
11 Tyr 0.0249 0.0274 0.0229
12 Phe 0.0157 0.0611 0.0324
13 Lys 0.0301 0.0203 0.0061
14 Asn 0.0926 0.0816 0.1148
15 His 0.0077 0.0049 0.0189
16 Arg 0.3093 0.2103 0.0346
17 Pro 1.6571 0.6375 1.5731
18 Total 3.7111 2.3244 3.5533
∗Can be detected, but cannot be quantiﬁed.
Table 5: Eﬀects of diﬀerent extracts on mice immune organs and phagocytosis.
Group Thymus index (mg/g) Spleen index (mg/g) Index of Phagocytosis K
Normal control 5.72 ±0.56 6.15 ±.0.94 0.038 ±0.008
Model 2.53 ±0.43## 3.04 ±0.46## 0.015 ±0.004##
Positive control 5.69 ±0.81
∗∗ 5.95 ±1.18
∗∗ 0.037 ±0.007
∗∗
MGHQ-TE 4.56 ±0.81
∗∗ 5.65 ±1.04
∗∗ 0.035 ±0.007
∗∗
MGHQ-FE 4.26 ±0.16
∗∗ 3.54 ±1.12 0.029 ±0.005
∗
MGHQ-SE 2.76 ±0.66 3.93 ±1.04 0.017 ±0.008
MGHQ-PE 4.96 ±0.76
∗∗ 6.05 ±1.04
∗∗ 0.036 ±0.006
∗∗
MGHQ-AE 3.96 ±0.42
∗ 3.89 ±0.58 0.031 ±0.004
∗∗
MJHQ-TE 4.76 ±0.66
∗∗ 6.05 ±1.04
∗∗ 0.032 ±0.011
∗
MJHQ-FE 3.42 ±0.48 4.08 ±1.12 0.021 ±0.009
MJHQ-SE 2.46 ±0.73 3.95 ±0.98 0.020 ±0.012
MJHQ-PE 4.98 ±0.85
∗∗ 5.82 ±0.72
∗∗ 0.039 ±0.004
∗∗
MJHQ-AE 2.76 ±0.66 4.05 ±1.21 0.016 ±0.007
HQ-TE 4.04 ±0.89
∗∗ 3.34 ±1.24 0.020 ±0.008
HQ-FE 3.06 ±0.67 4.01 ±1.14 0.030 ±0.004
∗∗
HQ-SE 2.96 ±0.96 3.95 ±0.84 0.015 ±0.006
HQ-PE 4.99 ±0.54
∗∗ 5.85 ±0.74
∗∗ 0.031 ±0.007
∗∗
HQ-AE 4.87 ±0.46
∗∗ 4.14 ±0.87 0.021 ±0.009
##P<. 01 and #P<. 05 versus the normal control group. ∗∗P<. 01 and ∗P<. 05 versus the model group.
activity in mice. Macrophages play a signiﬁcant role in the
host defense mechanism. Macrophages have the strong abil-
ity of phagocytosis and clearance variant particle diameter
or some dissolvability xenoma. When mice are injected via
the tail vein with carbon particles of a deﬁnite size, the
carbon particles will be cleared up in blood by macrophages
in the liver and spleen and by the total entire mononuclear
phagocytic system [28].
The eﬀects on mice immune organs and phagocytosis
from treatment with diﬀerent extracts are shown in Table 5
and Figure 4. Figure 4(a) shows that compared with the
model, the thymus indexes of mice treated with TE and PE of
thethreeherbsgroupssigniﬁcantlyincreased(P<. 01),while
PE groups wereobserved to have better eﬀect. In addition,
the thymus indexes of MGHQ-FE and HQ-AE groups
signiﬁcantly increased (P<. 01), and MGHQ-AE increased10 Journal of Biomedicine and Biotechnology
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Figure 5: Eﬀects of diﬀerent extracts treatment on mice serum
hemolysin ##P<. 01 and #P<. 05 versus the normal control group.
∗∗P<. 01 and ∗P<. 05 versus the model group.
Table 6: Eﬀects of diﬀerent extracts on mice serum hemolysin.
Group HC50
Normal control 118.3 ±19.4
Model 48.7 ±15.6##
Positive control 115.3 ±21.6
∗
MGHQ-TE 112.3 ±22.5
∗∗
MGHQ-FE 65.3 ±29.4
MGHQ-SE 80.1 ±17.1
∗
MGHQ-PE 102.3 ±21.5
∗∗
MGHQ-AE 85.3 ±17.3
∗∗
MJHQ-TE 77.3 ±15.4
MJHQ-FE 65.7 ±19.5
MJHQ-SE 95.3 ±13.7
∗∗
MJHQ-PE 108.3 ±20.4
∗∗
MJHQ-AE 71.3±20.3
HQ-TE 87.3±15.4∗
HQ-FE 97.1±14.7∗∗
HQ-SE 57.3±21.5
HQ-PE 105.7±22.8 ∗∗
HQ-AE 59.1±18.6
##P<. 01 and #P<. 05 versus the normal control group. ∗∗P<. 01 and
∗P<. 05 versus the model group.
the thymus index signiﬁcantly (P<. 05). Figure 4(b) shows
that the spleen indexes in all experimental groups increased
compared with the model, but this only became signiﬁcant
(P<. 01) in MGHQ-TE, MJHQ-TE, MGHQ-PE, MJHQ-PE,
and HQ-PE groups. Figure 4(c) shows that compared with
the model, the indexes of phagocytosis K in mice treated
with PE groups of all three herbs, MGHQ-TE, MGHQ-
AE, and HQ-FE groups signiﬁcant increased (P<. 01). In
addition, MGHQ-FE and MJHQ-TE increased the indexes
of phagocytosis K. The results showed that MGHQ-TE,
MGHQ-PE, MJHQ-TE, MJHQ-PE, and HQ-PE increased
the indexes of thymus, spleen, and phagocytosis K. The
polysaccharides extract (PE) may contain the bioactive com-
pounds which stimulated the nonspeciﬁcity immunological
activity in mice. PE in HQ showed similar activities with
those in MGHQ and MJHQ.
3.6. Eﬀect on Humoral Immune Responses. The level of a
speciﬁc antibody in the serum can be used as a measure of
the functional status of all three development phases of the
humoral immune response-antigen recognition, activation,
and expression [29]. Hemolysin level is usually considered
to be an indicator of humoral immunity. To determine an
extract’s eﬀect on the regulation of hemolysin, mice were
immunized with SRBC (T-dependent particulate antigen).
HC50, the absorbance at the time when hemolysin takes
place in half of SRBC, shows decreasing hemolysin and a
reduction in humoral immunity [30].
TheresultsareshowninTable 6.Figure 5showedthatthe
HC50 in all experimental groups increased compared with
the model, but this only became signiﬁcantly (P<. 01) in
PE groups of all the three herbs, MGHQ-TE, MGHQ-AE,
MJHQ-SE,andHQ-FEgroups.Inaddition,theHC50 ofmice
treated with MGHQ-SE and HQ-TE signiﬁcantly increased
(P<. 05). The results show that polysaccharides extract (PE)
may contain the bioactive compounds that inﬂuence speciﬁc
immunological activities, and PE in HQ showed similar
activities with those in MGHQ and MJHQ. HQ-FE showed
immunological activity in the assay of serum hemolysin to
SRBC, while FE of MGHQ and MJHQ did not. SE in MGHQ
and MJHQ showed immunological activity, while HQ-SE
did not. These results were consistent with the signiﬁcant
diﬀerences in the ﬂavonoid and saponin constituents in RA
and HQ.
4. Conclusions
In the present work, we have compared the chemical
constituents and the immunological eﬀects of MGHQ,
MJHQ, and HQ. We extracted and analyzed the components
of the three herbs, in ﬁve diﬀerent forms: total extract
(TE), ﬂavonoids extract (FE), saponins extract (SE), polysac-
charides extract (PE), and amino acids extract (AE), and
compared the immunological eﬀects of diﬀerent extracts by
using two immunological models.
The results showed that MGHQ and MJHQ had the
similar ﬂavonoid and saponin constituents, while HQ
was signiﬁcantly diﬀerent. Naringin and medicarpin were
only detected in HQ. The saponins in HQ are oleanane
pentacyclic triterpenoids, while the saponins in MGHQ
and MJHQ are cycloartane tetracyclic triterpenoids. In this
comparative study of speciﬁc immunological activity, HQ-
FE showed immunological activity in the assay of serum
hemolysin to SRBC, while FE of MGHQ and MJHQ did not.
SE in MGHQ and MJHQ showed immunological activity,
while HQ-SE did not.Journal of Biomedicine and Biotechnology 11
The contents of total amino acids were higher in MGHQ
and HQ than those in MJHQ. In this comparative study of
immunological activity, AE increased the indexes of thymus,
phagocytosis K and HC50 in mice signiﬁcantly, while AE
in MJHQ and HQ did not. The results show that AE in
MGHQ is very special. We could do more research on the
relationship of the percents of diﬀerent amino acids and the
immunological eﬀects in future.
Polysaccharides were the major constituents in MGHQ,
MJHQ, and HQ. The contents of polysaccharides in HQ
were almost double of those in MGHQ and MJHQ, but were
similar in MGHQ and MJHQ. In this comparative study of
nonspeciﬁc immunological activity, PE increased the indexes
of thymus, spleen, and phagocytosis K in mice signiﬁcantly.
In this comparative study of speciﬁc immunological activity,
PE increased HC50 in mice signiﬁcantly. In a conclusion, PE
showed regulatory eﬀects on both speciﬁc and nonspeciﬁc
immunological functions in mice. PE in HQ showed similar
activities with those in MGHQ and MJHQ. In a conclusion,
polysaccharides may be the main bioactive compounds that
are responsible for immunoregulatory function of RA and
HQ. Our studies provide the scientiﬁc data for that HQ can
be used instead of RA in the immunoregulatory function
aspect in the clinical application.
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